Genetic diagnosis of a Chinese multiple endocrine neoplasia type 2A family through whole genome sequencing
Authors:
- 11 May 2017
- journal article
- research article
- Published by Springer Nature in Journal of Biosciences
- Vol. 42 (2) , 209-218
Abstract
Approximately 98% of patients with multiple endocrine neoplasia type 2A (MEN 2A) have an identifiable RET mutation. Prophylactic or early total thyroidectomy or pheochromocytoma/parathyroid removal in patients can be preventative or curative and has become standard management. The general strategy for RET screening on family members at risk is to sequence the most commonly affected exons and, if negative, to extend sequencing to additional exons. However, different families with MEN 2A due to the same RET mutation often have significant variability in the clinical exhibition of disease and aggressiveness of the MTC, which implies additional genetic loci exsit beyond RET coding region. Whole genome sequencing (WGS) greatly expands the breadth of screening from genes associated with a particular disease to the whole genome and, potentially, all the information that the genome contains about diseases or traits. This is presumably due to additive effect of disease modifying factors. In this study, we performed WGS on a typical Chinese MEN 2A proband and identified the pathogenic RET p.C634R mutation. We also identified several neutral variants within RET and pheochromocytoma-related genes. Moreover, we found several interesting structural variants including genetic deletions (RSPO1, OVCH2 and AP3S1, etc.) and fusion transcripts (FSIP1-BAZ2A, etc.).Keywords
Funding Information
- National Natural Science Foundation of China (81472861)
This publication has 74 references indexed in Scilit:
- Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid CarcinomaThyroid®, 2015
- RET Fusion as a Novel Driver of Medullary Thyroid CarcinomaThe Journal of Clinical Endocrinology & Metabolism, 2015
- Genome-wide analysis of noncoding regulatory mutations in cancerNature Genetics, 2014
- Role of RET genetic variants in MEN2-associated pheochromocytomaEuropean Journal of Endocrinology, 2014
- High penetrance of pheochromocytoma in multiple endocrine neoplasia 2 caused by germ line RET codon 634 mutation in Japanese patientsEuropean Journal of Endocrinology, 2013
- The involvement of the RET variant G691S in medullary thyroid carcinoma: Conflicting results of meta-analyses need to be reconciledInternational Journal of Cancer, 2013
- Clinical Diagnosis by Whole-Genome Sequencing of a Prenatal SampleNew England Journal of Medicine, 2012
- ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive mannerNature, 2012
- RET genotypes in sporadic medullary thyroid cancer: studies in a large Italian seriesClinical Endocrinology, 2008
- Activation of a novel human transforming gene, ret, by DNA rearrangementCell, 1985